Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Treatments: Cadexomer iodine; Iodine; Povidone; Povidone-Iodine

Criteria

Inclusion Criteria:

• patients who were diagnosed with EKC at the outpatient ophthalmic unit

Exclusion Criteria:

• children younger than six years

• women being pregnant or during lactation

• history of allergy to povidone-iodine

• prior ocular surgery

• contact lens usage and chronic eye diseases with current eye medications.